Profile
Martin Lauriot Prévost is the founder and current Chairman of Ozyme SAS, which is founded in 1984.
He is also currently a Member-Supervisory Board at Nosopharm SAS.
Martin Lauriot Prévost active positions
Companies | Position | Start |
---|---|---|
Ozyme SAS
Ozyme SAS BiotechnologyHealth Technology Ozyme SAS is a distributor of reagents, instrumentation, and services in the fields of cellular biology, immunology, and molecular biology. The private company is based in Montigny-le-Bretonneux, France. and has subsidiaries in France. The French company was founded in 1984 by Martin Lauriot Prévost. | Founder | 1983-12-31 |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Ozyme SAS
Ozyme SAS BiotechnologyHealth Technology Ozyme SAS is a distributor of reagents, instrumentation, and services in the fields of cellular biology, immunology, and molecular biology. The private company is based in Montigny-le-Bretonneux, France. and has subsidiaries in France. The French company was founded in 1984 by Martin Lauriot Prévost. | Health Technology |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Health Technology |
- Stock Market
- Insiders
- Martin Lauriot Prévost